Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression

To evaluate botulinum toxin serotype A (BoNT-A) effects on sleep problems in children with cerebral palsy (CP) and on mothers` sleep quality and depression at multiple time points. This is a single center, cross sectional, and observational study was conducted to assess children with CP who were adm...

Full description

Saved in:
Bibliographic Details
Published in:Neurosciences (Riyadh, Saudi Arabia) Saudi Arabia), 2016-10, Vol.21 (4), p.331-337
Main Authors: Binay Safer, Vildan, Ozbudak Demir, Sibel, Ozkan, Esma, Demircioglu Guneri, Fulya
Format: Article
Language:English
Subjects:
Adult
Analysis
Anxiety
Botulinum toxins
Botulinum Toxins, Type A - therapeutic use
Cerebral palsied children
Cerebral palsy
Cerebral Palsy - complications
Cerebral Palsy - drug therapy
Child
Child, Preschool
Children
Cross-Sectional Studies
Depression (Mood disorder)
Depression - psychology
Female
Humans
Male
Mothers - psychology
Muscle Spasticity - drug therapy
Muscle Spasticity - etiology
Neuromuscular Agents - therapeutic use
Original
Psychiatric Status Rating Scales
Psychological aspects
Sleep
Sleep disorders
Sleep Wake Disorders - complications
Sleep Wake Disorders - physiopathology
Treatment Outcome
Turkey
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate botulinum toxin serotype A (BoNT-A) effects on sleep problems in children with cerebral palsy (CP) and on mothers` sleep quality and depression at multiple time points. This is a single center, cross sectional, and observational study was conducted to assess children with CP who were admitted. We recruited children with CP who were admitted to Ministry of Health Physical Medicine and Rehabilitation Training and Research Hospital, Ankara, Turkey between September 2012 and April 2014 for the BoNT-A injection for lower limb spasticity. Sleep quality of children with CP were determined at baseline and at the first, third and sixth month after the BoNT-A injection. Sleep quality Pittsburgh Sleep Quality Index (PSQI) and depression (by Beck Depression Inventory-II Turkish version) in mothers were also assessed. Twenty-four children with CP (7.05+/-2.69 years) underwent final assessment. Their bedtime resistance (11.71+/-3.26 versus (vs) 10+/-2.75, p
ISSN:1319-6138
1319-6138
DOI:10.17712/nsj.2016.4.20160207